Breaking Finance News

Insulet Corporation (NDAQ:PODD) stock price target increased to $65.00, issued a research note today by Barclays Capital

In a report announced on 9/15/2017 Barclays Capital raised the target price of Insulet Corporation (NDAQ:PODD) to $65.00 indicating a possible upside of 0.10%.

Yesterday Insulet Corporation (NDAQ:PODD) traded 0.39% higher at $59.10. The company’s 50-day moving average is $55.43 and its 200-day moving average is $47.48. The last stock close price is up 25.07% from the 200-day moving average, compared to the S&P 500 which has increased 0.04% over the same time. 320,395 shares of PODD traded hands, down from an average trading volume of 377,188

Recent Performance Chart

Insulet Corporation (NDAQ:PODD)

Insulet Corporation has 52 week low of $30.69 and a 52 week high of $59.97 and has a market capitalization of $0.

Brief Synopsis On Insulet Corporation (NDAQ:PODD)

Insulet Corporation is engaged in the development, manufacturing and sale of the OmniPod Insulin Management System (the OmniPod System), an insulin delivery system for people with insulin-dependent diabetes. The Omnipod System features a self-adhesive disposable tubeless Omnipod device, which is worn on the body for approximately three days at a time and its wireless companion, the handheld Personal Diabetes Manager (PDM). The Omnipod System features two discreet devices that eliminate the need for a bulky pump, tubing and separate blood glucose meter, provides for virtually pain-free automated cannula insertion, communicates wirelessly and integrates a blood glucose meter. The Omnipod System is a discreet two part design, the Omnipod device (Pod) and the PDM that eliminates the need for the external tubing required with conventional pumps. The Pod is a self-adhesive device that the patient fills with insulin and wears directly on the body.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *